Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$866.7M
Avg Funding
$34.7M
Global Reach
8
countries

Top Cities for Biopharma

Schlieren
Lidingö
Boston
Syracuse
Ithaca
Tarpon Springs

Recently Funded Companies

Export
Schlieren, Switzerland

LimmaTech Biologics is a biotech company that develops vaccines to prevent microbial infections and address antimicrobial resistance.

$6.5M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Lidingö, Sweden

This company is a Swedish medical technology company focused on improving the diagnosis and treatment of breast cancer.

$1.3M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Boston, United States

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

$193.0M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Syracuse, United States

BioNeex is a biopharma R&D open exchange platform and two-sided marketplace that directly connects biotech and biopharmaceutical.

$500K raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Ithaca, United States

Protogenix is developing a novel platform for protein production to replace the mammalian system.

$250K raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Tarpon Springs, United States

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

$3.3M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Carmel, United States

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

$30.0M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Hamilton, Canada

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

$60.0M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Vilnius, Lithuania

Pioneera Biosciences disrupts next-generation immune therapies through its immune orchestration platform

$5.3M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Paris, France

Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.

$5.3M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Barcelona, Spain

Affirma Biotech is a pre-clinical startup which develops host-directed drugs as treatments for chronic and infection diseases.

$1.9M raised
Feb 2024

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Michroma is a fungal biofactories to produce the next generation of ingredients.

$6.4M raised
Feb 2023

Founder Contacts

30,000+ verified contacts

Palm Beach, United States

Jupiter Biomedical Research is a company that offers commercial services.

$500K raised
Feb 2026

Founder Contacts

30,000+ verified contacts

California, Trinidad and Tobago

Basilard BioTech features a technology platform that transforms the rapidly growing cell-based therapies market.

Feb 2022

Founder Contacts

30,000+ verified contacts

Waltham, United States

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

$40.0M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Lille, France

4Moving Biotech is a biopharmaceutical company that develops osteoarthritis drugs for osteoarthritis patients.

$14.3M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Madrid, Spain

60Nd is a revolutionary technology used by bio and pharma researchers for in vitro mechanical simulation of cells and bio tissues.

$2.9M raised
Feb 2026

Founder Contacts

30,000+ verified contacts

Madrid, Spain

Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.

$15.5M raised
Feb 2025

Founder Contacts

30,000+ verified contacts

Hayward, United States

Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.

$400K raised
Feb 2024

Founder Contacts

30,000+ verified contacts

Woburn, United States

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

$39.6M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

$254.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Indapta Therapeutics is a privately held biotechnology company.

$50.8M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Seattle, United States

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

$30.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Portland, United States

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

$95.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

Salt AI is a contextual AI company that offers a visual development platform for enterprise applications in life sciences and health tech.

$10.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Showing 426 to 450 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$34.7M
Total Funding Tracked
$866.7M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Francisco
2 companies$57.2M
2.Madrid
2 companies$18.3M
3.Schlieren
1 companies$6.5M
4.Lidingö
1 companies$1.3M
5.Boston
1 companies$193.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked